Elanco Animal Health Incorporated

US$25.74As of Sun 8 Nov 2026, 12:00 UTC
NYSE:ELANHealthcare
Country USA
PE (Fwd) •••
TSR 8Y CAGR (3.68%)
Div yield —
ROE (2.20%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 1.72
PE TTM —
TSR TTM 16.21%
Mkt cap US$12.87B
ROIC 3.88%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$29
11.36%
(79.38%)
Hold 3|1|5|12|6
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.26
0.27
0.28
0.28
(1.73%)
(1.76%)
2.49%
5.22%
Revenue$B
1.132
1.144
1.197
1.204
6.74%
2.66%
8.34%
8.14%
Peers (US$12.87B)
Cap (US$)
PE
22.83B
—
12.72B
28.64x
Capital
TTM
5Y
10Y
Leveragex
1.695
(6.647)
(4.279)
EBIT/Intx
1.788
5.026
4.831
Own earn%
4.29
(36.90)
(17.73)
Sh yield%
19.71
22.38
29.29
Owners
Insiders/Inst%
4.77
77.66
Short interest%
1.66
SBC / revenue%
4.22
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
5–11
$1 testx
0.0
Incr. ROIC%
4